Vulnerability in Oracle Life Sciences Empirica Signal

CVE-2026-21997

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N.

EPSS exploit prediction

EPSS: 0.002 (9.1th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 9th percentile — 9.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-21997: held from 0.002 to 0.002.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-21997?
CVE-2026-21997 is a high-severity vulnerability in Oracle Life Sciences Empirica Signal, classified under Improper Access Control. CVSS score: 8.5/10. Published 2026-04-21.
How severe is CVE-2026-21997?
High severity. CVSS v3 base score is 8.5 out of 10.